Abstract
AbstractThe number of “omics” approaches is continuously growing. Among others, epigenetics has appeared as an attractive area of investigation by the cardiovascular research community, notably considering its association with disease development. Complex diseases such as cardiovascular diseases have to be tackled using methods integrating different omics levels, so called “multi-omics” approaches. These approaches combine and co-analyze different levels of disease regulation. In this review, we present and discuss the role of epigenetic mechanisms in regulating gene expression and provide an integrated view of how these mechanisms are interlinked and regulate the development of cardiac disease, with a particular attention to heart failure. We focus on DNA, histone, and RNA modifications, and discuss the current methods and tools used for data integration and analysis. Enhancing the knowledge of these regulatory mechanisms may lead to novel therapeutic approaches and biomarkers for precision healthcare and improved clinical outcomes.
Funder
Ministry of Education, Science and Technological Development, Republic of Serbia
European Union
American Heart Association
Colorado Clinical and Translational Sciences Institute
Alan Turing Institute
Ricerca Corrente - Rete cardiologica IRCCS
Italian Ministry of Health
Italian Cardiology Network IRCCS
Telethon Foundation
AFM-Telethon
EU Horizon 2020
cardioRNA COST action
Fonds National de la Recherche Luxembourg
CardioRNA COST action
Ministère de l'Enseignement Supérieur et de la Recherche
Heart Foundation—Daniel Wagner of Luxembourg
Regione Lombardia
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献